158 related articles for article (PubMed ID: 27785616)
1. PEPCK-C reexpression in the liver counters neonatal hypoglycemia in Pck1
Semakova J; Hyroššová P; Méndez-Lucas A; Cutz E; Bermudez J; Burgess S; Alcántara S; Perales JC
J Physiol Biochem; 2017 Feb; 73(1):89-98. PubMed ID: 27785616
[TBL] [Abstract][Full Text] [Related]
2. Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction.
Vieira P; Cameron J; Rahikkala E; Keski-Filppula R; Zhang LH; Santra S; Matthews A; Myllynen P; Nuutinen M; Moilanen JS; Rodenburg RJ; Rolfs A; Uusimaa J; van Karnebeek CDM
Mol Genet Metab; 2017 Apr; 120(4):337-341. PubMed ID: 28216384
[TBL] [Abstract][Full Text] [Related]
3. PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis.
Méndez-Lucas A; Duarte JA; Sunny NE; Satapati S; He T; Fu X; Bermúdez J; Burgess SC; Perales JC
J Hepatol; 2013 Jul; 59(1):105-13. PubMed ID: 23466304
[TBL] [Abstract][Full Text] [Related]
4. PCK1 and PCK2 as candidate diabetes and obesity genes.
Beale EG; Harvey BJ; Forest C
Cell Biochem Biophys; 2007; 48(2-3):89-95. PubMed ID: 17709878
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic phosphoenolpyruvate carboxykinase deficiency: Expanding the clinical phenotype and novel laboratory findings.
Vieira P; Nagy II; Rahikkala E; Väisänen ML; Latva K; Kaunisto K; Valmari P; Keski-Filppula R; Haanpää MK; Sidoroff V; Miettinen PJ; Arkkola T; Ojaniemi M; Nuutinen M; Uusimaa J; Myllynen P
J Inherit Metab Dis; 2022 Mar; 45(2):223-234. PubMed ID: 34622459
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation.
She P; Burgess SC; Shiota M; Flakoll P; Donahue EP; Malloy CR; Sherry AD; Magnuson MA
Diabetes; 2003 Jul; 52(7):1649-54. PubMed ID: 12829628
[TBL] [Abstract][Full Text] [Related]
7. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism.
She P; Shiota M; Shelton KD; Chalkley R; Postic C; Magnuson MA
Mol Cell Biol; 2000 Sep; 20(17):6508-17. PubMed ID: 10938127
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.
Burgess SC; He T; Yan Z; Lindner J; Sherry AD; Malloy CR; Browning JD; Magnuson MA
Cell Metab; 2007 Apr; 5(4):313-20. PubMed ID: 17403375
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase.
Caton PW; Nayuni NK; Murch O; Corder R
Life Sci; 2009 May; 84(21-22):738-44. PubMed ID: 19268478
[TBL] [Abstract][Full Text] [Related]
10. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
Gómez-Valadés AG; Méndez-Lucas A; Vidal-Alabró A; Blasco FX; Chillon M; Bartrons R; Bermúdez J; Perales JC
Diabetes; 2008 Aug; 57(8):2199-210. PubMed ID: 18443203
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia in the newborn growth-retarded rat: delayed phosphoenolpyruvate carboxykinase induction despite increased glucagon availability.
Bussey ME; Finley S; LaBarbera A; Ogata ES
Pediatr Res; 1985 Apr; 19(4):363-7. PubMed ID: 3889814
[TBL] [Abstract][Full Text] [Related]
12. [Postnatal development of gluconeogenic key enzymes, phosphoenolpyruvate carboxykinase and pyruvate carboxylase, in pig liver].
Grün E; Pfüller K
Acta Biol Med Ger; 1982; 41(6):515-23. PubMed ID: 7148263
[TBL] [Abstract][Full Text] [Related]
13. Phosphoenolpyruvate carboxykinase cytosolic and mitochondrial isoforms are expressed and active during hypoxia in the white shrimp Litopenaeus vannamei.
Reyes-Ramos CA; Peregrino-Uriarte AB; Cota-Ruiz K; Valenzuela-Soto EM; Leyva-Carrillo L; Yepiz-Plascencia G
Comp Biochem Physiol B Biochem Mol Biol; 2018 Dec; 226():1-9. PubMed ID: 30107223
[TBL] [Abstract][Full Text] [Related]
14. Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA.
Banzet S; Koulmann N; Simler N; Sanchez H; Chapot R; Serrurier B; Peinnequin A; Bigard X
J Appl Physiol (1985); 2009 Dec; 107(6):1830-9. PubMed ID: 19850730
[TBL] [Abstract][Full Text] [Related]
15. Transcription of hepatic cytosolic phosphoenolpyruvate carboxykinase gene in newborn dogs.
Feng BC; Li J; Kliegman RM
Biochem Mol Med; 1996 Oct; 59(1):13-9. PubMed ID: 8902188
[TBL] [Abstract][Full Text] [Related]
16. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.
Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
J Biol Chem; 2013 Jul; 288(27):19739-49. PubMed ID: 23689508
[TBL] [Abstract][Full Text] [Related]
17. The effect of dexamethasone and surgically induced intrauterine growth retardation on renal and hepatic levels of phosphoenolpyruvate carboxykinase in the rat.
Levitsky LL; Edidin DV; Menella JA; Spaulding NH; Hsieh LC
Biol Neonate; 1986; 49(1):36-42. PubMed ID: 3947691
[TBL] [Abstract][Full Text] [Related]
18. Two cases of phosphoenolpyruvate carboxykinase deficiency.
Hommes FA; Bendien K; Elema JD; Bremer HJ; Lombeck I
Acta Paediatr Scand; 1976 Mar; 65(2):233-40. PubMed ID: 176867
[TBL] [Abstract][Full Text] [Related]
19. Multitissue 2H/13C flux analysis reveals reciprocal upregulation of renal gluconeogenesis in hepatic PEPCK-C-knockout mice.
Rahim M; Hasenour CM; Bednarski TK; Hughey CC; Wasserman DH; Young JD
JCI Insight; 2021 Jun; 6(12):. PubMed ID: 34156032
[TBL] [Abstract][Full Text] [Related]
20. Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families.
Al Busaidi M; Mohamed FE; Al-Ajmi E; Al Hashmi N; Al-Thihli K; Al Futaisi A; Al Mamari W; Al-Murshedi F; Al-Jasmi F
Orphanet J Rare Dis; 2023 Nov; 18(1):344. PubMed ID: 37924129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
